𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum β2 microglobulin in malignant lymphoproliferative disorders

✍ Scribed by Ioannis P. Constantinides; Christina Pathouli; Gerasimos Karvountzis; Perikles Papadopoulos; Maria Varvoutsi-Constantinides; Polivios Eliakis; Stephanos Hadziyannis; Zacharias Komninos

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
508 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum β2-microglobulin levels in primary
Serum β2-microglobulin levels in primary biliary cirrhosis
✍ Anders Nyberg; Lars Lööf; Roger Hällgren 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

Serum &-microglobulin (&p) was determined in 44 patients with primary biliary cirrhosis (PBC) and in 63 patients with other liver disorders. Bzp levels were elevated in PBC when compared with chronic persistent hepatitis, primary sclerosing cholangitis and noncirrhotic alcohol liver disease, but not

Serum β2-microglobulin and SLE
Serum β2-microglobulin and SLE
✍ M. Weissel; O. Scherak; H. Fritzsche; G. Kolarz 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views
Serum-soluble interleukin-2 receptors in
Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies
✍ Pavlidis, Nicholas A. ;Manoussakis, Menelaus N. ;Germanidis, George S. ;Moutsopo 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

## Abstract The levels of soluble interleukin‐2 receptors (sIL‐2R) were determined in the serum of 53 patients with B‐cell lymphoproliferative malignancies, including 31 patients with non‐Hodgkin lymphomas (NHL), 16 with chronic lymphocytic leukemia (CLL), and 6 with multiple myeloma. In addition,